Close search filters
Changing filters will change the listed Success Criteria and Techniques
Category
Topic
Search results (630)
Article
Leveraging biosimilars to drive savings and support patient access
July 01, 2024
By the end of 2024, 3 FDA-approved biosimilars to Stelara for patients living with inflammatory conditions will be closer to launch, enabling lower total drug spend.
Article
Cardiodiabesity 101
July 13, 2023
More than half of U.S. adults suffer from cardiovascular disease, diabetes or obesity and a growing number experience all three. Plan sponsors can take action to address this increasingly complex chal...
Article
Why is prenatal care vital to a happy and healthy pregnancy?
July 07, 2023
Pregnant individuals require routine, dedicated care to ensure positive parental and fetal outcomes.
Newsroom
Express Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients
July 10, 2023
Article
A plan sponsor’s guide to GLP-1 medications for weight loss
July 10, 2023
GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population of the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...
Report
Immune checkpoint inhibitor medications: A game-changer in cancer treatments
A report from the Evernorth Research Institute offers insights that can help health plans optimize cancer care.
Read More